Benzonatate
Other Cough Suppressants
- Drug class
- Other Cough Suppressants
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 9
- FDA reports (12 mo)
- 1,441
Overview
Benzonatate is an active pharmaceutical ingredient in the Other Cough Suppressants group (R05DB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 9 | April 7, 2026 |
USUnited States· FDA
9 products
Uses
INDICATIONS AND USAGE
Benzonatate Capsule is indicated for the symptomatic relief of cough.
How to take
Drug interactions
Known interactions involving Benzonatate. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 07018b47-76f5-49… · revised February 2, 2026 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.